Boost Your Biology with Lucas Aoun · Lucas Aoun

300. Stem Cell Therapy & Regenerative Medicine With Dr. Adeel Khan

·58 min·5 clips

Muse stem cells can turn into over 200 cell types without causing cancer, unlike traditional stem cells.

Dr. Adeel Khan, a regenerative medicine specialist, joins host Lucas Aoun to discuss stem cell therapies and their evolution. The conversation explores Dr. Khan's journey into the field, prompted by his mother's chronic illnesses and the limitations of conventional healthcare. He explains his initial focus on Platelet-Rich Plasma (PRP) therapy, pioneered by Dr. Anthony Galea for athletes like Tiger Woods. Dr. Khan describes his current toolkit as expanding far beyond PRP to include exosomes, various stem cells, peptides, and advanced diagnostics. A significant portion of the discussion details the progression from first-generation mesenchymal stem cells, which he notes are primarily anti-inflammatory, to more potent options. Dr. Khan highlights the promise of Muse cells, or multilineage differentiating stress-enduring cells, as a second-generation stem cell. He explains these cells are pluripotent, capable of turning into over 200 cell types, but are non-tumorigenic and can survive in harsh environments. Unlike many stem cells, Muse cells possess a homing mechanism, sensing tissue damage signals like S1P to target areas of inflammation, which allows for intravenous administration. The doctor references a clinical trial in Japan where Muse cells were delivered via IV to treat stroke patients. He notes that for conditions like chronic pain, treatment is often "one and done," while for longevity, infusions might be repeated every six to twelve months. Dr. Khan emphasizes optimizing the cellular environment for these therapies by reducing oxidative stress and supporting mitochondrial function. He discusses specific peptides like SS-31, which stabilizes cardiolipin in the mitochondrial membrane, and MOTS-c, which may improve cardiovascular function. Dr. Khan also mentions the peptide retatrutide for improving insulin sensitivity and metabolic health. He shares anecdotal observations that stem cell therapies can aid in "metabolic reprogramming," converting white fat to healthier beige fat. Accessibility is addressed, with current costs for such therapies ranging from thousands to tens of thousands of dollars, though Dr. Khan hopes for broader insurance coverage in the future. He mentions using diagnostic tests from a company called Generation Lab to measure biological age through "biological noise" or genetic errors. The episode maintains an educational and conversational tone, blending scientific explanations with clinical anecdotes and future-facing optimism. Listeners interested in cutting-edge longevity interventions, advanced biohacking, and alternatives to conventional chronic disease management will find this compelling. Those seeking strictly proven, widely available medical treatments or who are skeptical of emerging regenerative therapies may prefer to skip it.

As heard by us

A technical health conversation that treats peptides as a possible next frontier beyond supplements.

Lucas Owen frames Boost Your Biology as a broad health conversation that moves through hormones, nutrition, supplementation, fat loss, biohacking, longevity, and wellness.

Read the full review in PlayNext →

Why you'd press play

You want the frontier of longevity without waiting for it to become mainstream.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Boost Your Biology with Lucas Aoun